Paschou SA, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D, Goulis DG. Type 2 diabetes and osteoporosis: a guide to optimal management. J Clin Endocrinol Metab. 2017;102:3621–34.
Leslie WD, Morin SN. New developments in fracture risk assessment for current osteoporosis reports. Curr Osteoporos Rep. 2020;18:115–29.
Si Y, Wang C, Guo Y, Yin H, Ma Y. Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese mainland: A protocol of systematic review and meta-analysis. Medicine. 2020;99:e19762.
Holloway-Kew KL, Marijanovic N, De Abreu LLF, Sajjad MA, Pasco JA, Kotowicz MA. Bone mineral density in diabetes and impaired fasting glucose. Osteoporos Int. 2019;30:1799–806.
Liu JM, Zhu DL, Mu YM, Xia WB, Chinese Society of Osteoporosis and Bone Mineral Research, the Chinese Society of Endocrinology, Chinese Diabetes Society, Chinese Medical Association; Chinese Endocrinologist Association, Chinese Medical Doctor Association. Management of fracture risk in patients with diabetes-Chinese Expert Consensus. J Diabetes. 2019;11:906–19.
Lee TC, Lee YL, Chen JC, Chen CH, Ho PS. Impact of type 2 diabetes on postoperative outcome after hip fracture: nationwide population-based study in Taiwan. BMJ Open Diabetes Res Care. 2020;8:e000843.
Kurra S, Fink DA, Siris ES. Osteoporosis-associated fracture and diabetes. Endocrinol Metab Clin North Am. 2014;43:233–43.
Wu ZJ, He JL, Wei RQ, Liu B, Lin X, Guan J, et al. C-reactive protein and risk of fracture: a systematic review and dose-response meta-analysis of prospective cohort studies. Osteoporos Int. 2015;26:49–57.
Xiu S, Chhetri JK, Sun L, Mu Z, Wang L. Association of serum prealbumin with risk of osteoporosis in older adults with type 2 diabetes mellitus: a cross-sectional study. Ther Adv Chronic Dis. 2019;10:2040622319857361.
Lee EA, Shin DW, Yoo JH, Ko HY, Jeong SM. Anemia and risk of fractures in older korean adults: a nationwide population-based study. J Bone Min Res. 2019;34:1049–57.
Pan ML, Chen LR, Tsao HM, Chen KH. Iron deficiency anemia as a risk factor for osteoporosis in Taiwan: a nationwide population-based study. Nutrients. 2017;9:616.
Seitz AE, Eberhardt MS, Lukacs SL. Anemia prevalence and trends in adults aged 65 and older: U.S. national health and nutrition examination survey: 2001-2004 to 2013-2016. J Am Geriatr Soc. 2018;66:2431–2.
Gauci R, Hunter M, Bruce DG, Davis WA, Davis TME. Anemia complicating type 2 diabetes: Prevalence, risk factors and prognosis. J Diabetes Complications. 2017;31:1169–74.
Fujimoto H, Fujimoto K, Ueda A, Ohata M. Hypoxemia is a risk factor for bone mass loss. J Bone Min Metab. 1999;17:211–6.
Cesari M, Pahor M, Lauretani F, Penninx BW, Bartali B, Russo R, et al. Bone density and hemoglobin levels in older persons: results from the InCHIANTI study. Osteoporos Int. 2005;16:691–9.
Laudisio A, Marzetti E, Pagano F, Bernabei R, Zuccalà G. Haemoglobin levels are associated with bone mineral density in the elderly: a population-based study. Clin Rheumatol. 2009;28:145–51.
Korkmaz U, Korkmaz N, Yazici S, Erkan M, Baki AE, Yazici M, et al. Anemia as a risk factor for low bone mineral density in postmenopausal Turkish women. Eur J Intern Med. 2012;23:154–8.
Kim SY, Yoo DM, Min C, Choi HG. Association between osteoporosis and low hemoglobin levels: a nested case-control study using a national health screening cohort. Int J Environ Res Public Health. 2021;18:8598.
Oh YH, Moon JH, Cho B. Association between hemoglobin level and bone mineral density in korean adults. J Bone Metab. 2017;24:161–73.
World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva.
WHO Scientific Group. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep. Ser. 1968;405:5–37.
Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4:368–81.
Eckardt KU, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis—a position statement from KDOQI and KDIGO. Am J Kidney Dis. 2009;53:915–20.
Thomas MC, Tsalamandris C, MacIsaac RJ, Jerums G. The epidemiology of hemoglobin levels in patients with type 2 diabetes. Am J Kidney Dis. 2006;48:537–45.
Ezenwaka CE, Jones-Lecointe A, Nwagbara E, Seales D, Okali F. Anaemia and kidney dysfunction in Caribbean type 2 diabetic patients. Cardiovasc Diabetol. 2008;7:25.
Angelousi A, Larger E. Anaemia, a common but often unrecognized risk in diabetic patients: a review. Diabetes Metab. 2015;41:18–27.
Wu LY, Yang TC, Kuo SW, Hsiao CF, Hung YJ, Hsieh CH, et al. Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res. 2003;29:317–25.
Onal ED, Usluogullar A. Anemia and osteoporosis: Causal association or epiphenomenon? Eur J Intern Med. 2012;23:e117.
Wang M, Wang X, Cui W, Zhu G, Liang Y, Chen X, et al. The association between hemoglobin level and osteoporosis in a Chinese population with environmental lead and cadmium exposure. Environ Geochem Health. 2021. https://doi.org/10.1007/s10653-021-01129-0.
Lewerin C, Nilsson-Ehle H, Jacobsson S, Johansson H, Sundh V, Karlsson MK, et al. Serum estradiol associates with blood hemoglobin in elderly men: the MrOS Sweden study. J Clin Endocrinol Metab. 2014;99:2549–56.
Kenny AM, Prestwood KM, Marcello KM, Raisz LG. Determinants of bone density in healthy older men with low testosterone levels. J Gerontol A Biol Sci Med Sci. 2000;55:M492–M497.
Karadag F, Cildag O, Yurekli Y, Gurgey O. Should COPD patients be routinely evaluated for bone mineral density? J Bone Min Metab. 2003;21:242–6.
Utting JC, Flanagan AM, Brandao-Burch A, Orriss IR, Arnett TR. Hypoxia stimulates osteoclast formation from human peripheral blood. Cell Biochem Funct. 2010;28:374–80.
Baraldi-Junkins CA, Beck AC, Rothstein G. Hematopoieis and cytokines. Relevance Cancer Aging Hematol Oncol Clin North Am. 2000;14:45–61.
Shahen VA, Gerbaix M, Koeppenkastrop S, Lim SF, McFarlane KE, Nguyen ANL, et al. Brennan-Speranza TC. Multifactorial effects of hyperglycaemia, hyperinsulinemia and inflammation on bone remodelling in type 2 diabetes mellitus. Cytokine Growth Factor Rev. 2020;55:109–18.
Shiozawa Y, Taichman RS. Bone: Elucidating which cell erythropoietin targets in bone. Nat Rev Endocrinol. 2015;11:263–4.
Singh DK, Winocour P, Farrington K. Erythropoietic stress and anemia in diabetes mellitus. Nat Rev Endocrinol. 2009;5:204–10.
Mojiminiyi OA, Abdella NA, Zaki MY, El Gebely SA, Mohamedi HM, Aldhahi WA. Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus. Diabet Med. 2006;23:839–44.
Lanier JB, Park JJ, Callahan RC. Anemia in older adults. Am Fam Physician. 2018;98:437–42.
留言 (0)